Combination therapy for HCV infection

Details for Australian Patent Application No. 2004281747 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Kauffman, Robert Stephen; Alam, John J.; Ette, Ene

Agent Cullen & Co

Pub. Number AU-A-2004281747

PCT Pub. Number WO2005/037274

Priority 60/510,733 11.10.03 US

Filing date 12 October 2004

Wipo publication date 28 April 2005

International Classifications

A61K 31/7056 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/037274 Priority application(s): WO2005/037274

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281750-Method of treating vasomotor symptoms

2004281746-12' (1, 4'-biperidin-1'-yl)-1- (phenyl) - ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms